Market Scenario
Dental surgical and diagnostic devices are the medical devices used for the diagnosis and the treatment of the dental problems. Increasing prevalence of dental problems, rising geriatric population, development in the dental surgical and diagnostic devices drive the global market. Moreover, changing lifestyle and increasing consumption of drugs contributes to the growth of the market. However, high cost of the devices may hinder the growth of the market over the forecast period. The global dental surgical and diagnostic devices market is expecting a sound growth at a health CAGR of 11.2% during the forecasted period. Segmentation The global dental surgical & diagnostic devices market is segmented into product types, application and end users. The market is segmented On the basis of product type: CAD/CAM systems, dental chairs, dental radiology devices, CBCT scanners, scaling units, dental lasers. CAD/CAM systems is further segmented into full in-lab systems, stand-alone scanners, and chair-side systems. Dental radiology devices are sub-segmented into Phosphor Storage Plates (PSP), digital x-ray, accessories, dental imaging devices. Dentals lasers market is further segmented into soft tissue laser and all hard tissue laser market. The soft tissue laser is subdivided into gas laser, diode laser, and solid state lasers. On the basis of applications: The market is segmented into bone abnormalities, cysts, fractures, reconstructive postmortem dental profiling, and comparative dental identification. On the basis of end user: The market is segmented into dentists, hospitals, and others. Intended Audience · Dental Surgical Devices Manufacturer and Supplier · Dental Diagnostic Devices Manufacturer and Supplier · Research and Development (R&D) Companies · Independent Research Laboratories · Market Research and Consulting Service Providers · Medical Research Laboratories · Academic Medical Institutes and Universities Regional Analysis America dominates the dental surgical and diagnostic devices market owing to the presence of the huge geriatric population and continuously increasing patient number. According to the National Institute of Dental and Craniofacial Research (2016), in America, 80% of the adults aged 20 - 64 years have dental cavity or tooth decay. According to the Centers for Disease Control and Prevention (2015), 50% American adults aged over 30 have periodontal diseases. Furthermore, high spending on healthcare and well-developed infrastructure have also help in the growth of the market. Europe holds the second position in the global market followed by Asia Pacific. Asia Pacific is the fastest growing market due to the presence of the huge opportunities, rising population base, increasing awareness about the dental care, and oral health hygiene, and continuously increasing demand. However, the Middle East and Africa accounts for the least market share. Some of the major players in the market are 3M (US), A-dec Inc. (US), Carestream Health (US), Danaher (US), American Medicals (US), Dentsply Sirona. (Germany), Ivoclar Vivadent, Inc. (Liechtenstein), Hu-Friedy Mfg. Co., LLC (US), PLANMECA OY (Finland), Midmark Corp. (US), KaVo Kerr (US), GC Corporation (Japan), DCI (US). The global dental surgical & diagnostic devices market is experiencing extreme competition due to major companies are focusing on the development of new and advances devices to overcome the disadvantages of present available devices. Some major has adopted strategies of acquisitions and strategic alliances for the growth of the market. 3M is the American multinational company focuses on the manufacturing and distribution of the number of different products. The company manufacture number of products such as dental and orthodontic products, medical products, personal protective equipment, electronic materials, and many more. Filtek, Clinpro, ESPE Peridex, Protemp Plus, and Scotchbond. Carestream Health, headquartered in Canada, is one of the largest corporations in Canada and involved in manufacturing of the different dental surgical and diagnostic devices such as radiology department products, medical printing products, healthcare it products. get full report @ https://www.marketresearchfuture.com/reports/dental-surgical-diagnostic-devices-market-724 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
0 Comments
Market Research Future published a study report on Global Ischemic strokes Market. This report studies the global market size, industry status and forecast, competition landscape and growth opportunity. Ischemic strokes Market research report categorizes the market by companies, region, type and end-use industry.
Market Scenario: Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis. According to the World Health Organization (WHO), stroke accounts for around 17 million deaths annually. As per the Centers for Disease Control and Prevention (CDC), stroke leads to 1 out of every 20 deaths costing around USD 34 billion each year in the U.S. Higher rates of mortality associated with strokes highlight an impending need for innovative drugs and diagnostic devices. The key strategies adopted by leading industry players incldues new product launches and collaborations. For instance, in April 2016, the novel TransCarotid Artery Revascularization (TCAR) procedure launched by Silk Road Medical, Inc, received FDA approval. This minimally invasive technique is designed to access the common carotid artery. Moreover, in March, 2015, WATCHMAN, a closure device designed to prevent stroke in patients with atrial fibrillation received FDA approval. Rising cases of ischemia stroke are driving the demand for surgical procedures in stroke treatment. Increasing demand for minimally invasive procedures and advancements in surgical procedures are the key factors boosting the growth of the global ischemic stroke market. High cost of the surgical procedures and excessive usage of medication for the treatment of ischemic stroke are hindering the market growth. The Ischemic strokes Market is expected to grow at a CAGR of approximately 8.3% during the forecast period 2017-2023. Market Segmentation of Ischemic strokes Market: The ischemic stroke is segmented on the basis of diagnosis, drug class, surgery and end-users. On the basis of the diagnosis, the market is segmented into Computed Tomography (CT), Magnetic resonance imaging (MRI), carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others. On the basis of the drug class, the market is segmented into tissue plasminogen activator, anticoagulant, antiplatelet, antihypertensive, and others On the basis of the surgery, the market is segmented into carotid endarterectomy, angioplasty, and endovascular mechanical thrombectomy On the basis of the end-user, the market is segmented into hospitals & clinics, medical institutes, research organization, and others. Top Players in Ischemic strokes Market: Abbott Laboratories (U.S.), Medtronic plc (U.S.), Boston Scientific Corporation (U.S.), Cordis Corporation (U.S.), Koninklijke Philips N.V. (Netherland), GE Healthcare (U.S.), Stryker Corporation (U.S.), Genentech, Inc. (U.S.), Merck & Co., Inc. (U.S.), Bayer AG (Germany), Boehringer Ingelheim (Germany), Sanofi (France), Covidien plc (Ireland), Philips Healthcare (U.S.), Johnson & Johnson (U.S.), Penumbra, Inc. (U.S.), GE Healthcare (U.S.), Siemens Healthcare (U.S.), Hitachi, Ltd (Japan), Biogen (U.S.), Daiichi Sankyo (U.S.), Pfizer Inc. (U.S.), and others The emergence of new and cost-effective medication options for the treatment of ischemic stroke could open up new opportunities to the new players in the global ischemic stroke market. Additionally, emerging markets, such as India and China, could also open new opportunities to new players. Intended Audience
The global ischemic stroke market consists of countries namely America, Europe, Asia Pacific, and the Middle East and Africa. The Americas has emerged as the largest market for the global ischemic stroke owing to the favorable government initiatives, technological innovations, and increasing demand for ischemic stroke products. According to the American Heart Association, ischemic stroke is among the top three causes of death in the U.S. and Canada, nearly 795,000 patients suffering from strokes are treated in the 2014. Europe is the second largest global ischemic stroke market owing to the advancements in the surgical devices technology along with the rising occurrence of acute ischemia stroke cases among the patients. In the European Union, over 31 million people are living with diabetes aged between 20 and 79. This signifies an average diabetes prevalence rate of 8.6% of the adult population. Some other factors driving the market includes the growing percentage of diabetes mellitus population mainly in the developed countries of Europe Asia Pacific is anticipated to unfold as the most promising market for the global ischemic stroke owing to increasing prevalence of stroke cases in this region. China and India are considered as a big market for ischemic stroke within the forecast period. Manufacturers are expanding their operations in Asia Pacific region as these regions hold immense potential for the market growth. The Middle East region is expected to grow at a faster rate due to the factors such as the extensive development of healthcare infrastructure and growing emphasis on research and development in the healthcare sector. get full report @https://www.marketresearchfuture.com/reports/ischemic-stroke-market-5423 About US: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Global Merkel Cell Carcinoma Market Research Report: By Diagnosis (Physical Examination, Sentinel Node Biopsy, Imaging Test), Treatment (Surgery, Radiation Therapy, Chemotherapy), End User (Hospitals & Clinics, Diagnostic Centers) – Forecast till 2023
Industry Report “Merkel Cell Carcinoma Market Research Report - Global Forecast till 2023” provides a clear picture of the Current Market Scenario which includes past and estimated future size with respect to value and volume, technological advancement. The report provides detail information and strategies of top key players in the industry. The report also gives a broad study about different markets segments and regions. Market Research Future (MRFR)’s latest study reveals that the global merkel cell carcinoma market is projected to strike a CAGR of 7.40% during the forecast period. The growing geriatric population is likely to dictate the growth of the market as this disease majorly affects the elderly population. Market Segmentation: By diagnosis, the merkel cell carcinoma market has been segmented into physical examination, sentinel node biopsy, imaging tests, and others. The imaging tests segment is further sub-segmented into computed tomography (CT), X-ray, positron emission tomography (PET), and others. By treatment, the global merkel cell carcinoma market has been segmented into surgery, chemotherapy, radiation therapy, and others. The chemotherapy segment is sub-segmented into cisplatin, etoposide, and others. By end user, the merkel cell carcinoma market has been segmented into hospitals & clinics, research organization, diagnostic centers, and others. Competitive Dashboard: Some of the prominent players operating in the merkel cell carcinoma market are Pfizer Inc. (U.S.), OncoSec Medical Incorporated (U.S.), Merck & Co., Inc. (U.S.), AstraZeneca (U.K), Bristol-Myers Squibb Company (U.S.), Siemens Medical Solutions USA, Inc. (Germany), CANON MEDICAL SYSTEMS CORPORATION (Japan), General Electric Company (U.S.), Philips Health Care (The Netherlands), and Mediso Ltd. Endomagnetics Limited (Hungary). Get Detailed Analysis of Global Merkel Cell Carcinoma Market Research Report: By Diagnosis (Physical Examination, Sentinel Node Biopsy, Imaging Test), Treatment (Surgery, Radiation Therapy, Chemotherapy), End User (Hospitals & Clinics, Diagnostic Centers) – Forecast till 2023 @ https://www.marketresearchfuture.com/reports/merkel-cell-carcinoma-market-5343 Industry News: In January 2019, the U.S. based NantKwest Inc. has announced the launch of Merkel Cell Carcinoma Phase II Trial, novel triple combination. Related news Krabbe Disease Treatment Market Research Report- Forecast to 2022 Bone Densitometers Market Research Report- Forecast to 2022 About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. Contact https://www.marketresearchfuture.com/ Market Highlights
According to MRFR analysis, Pseudomonas Aeruginosa Treatment Market is expected to register a CAGR of 7% during the forecast period of 2019 to 2025 and is likely to be valued at USD 7.5 Billion in 2025. Pseudomonas Aeruginosa is a soil bacterium that causes diseases in a plant, animal and humans. It has an antibiotic resistance property because of which it creates life-threatening conditions that are difficult to treat. Pseudomonas Aeruginosa is one of the key reasons for having surgical site infection and hospital-acquired infection in patient hospitalized for a longer period. It is estimated that around 1.7 million patient suffers from hospital acquire infection and 99,000 dies each year from the same. The growth of the global Pseudomonas Aeruginosa treatment market is determined by numerous factors such as an increasing number of surgeries, a growing geriatric population, increasing cases of hospital-acquired infection, which is directly responsible for increasing global Pseudomonas Aeruginosa treatment market. However, the side effects associated with the medication and lack of awareness about the disease caused due to Pseudomonas Aeruginosa are likely to hamper the growth of the global Pseudomonas Aeruginosa treatment market during the forecast period. Several market players currently dominate the global Pseudomonas Aeruginosa treatment market. The key players are involved in product launches and strategic collaborations to strengthen their market positions. Segmentation The Global Pseudomonas Aeruginosa Treatment Market has been segmented based on medication, route of administration, and distribution channel. The market, based on medication, has been divided into monotherapy and combination therapy. Combination therapy is likely to hold the maximum market share in the global Pseudomonas Aeruginosa treatment market. The global Pseudomonas Aeruginosa treatment market on the basis of route of administration has been segregated into nasal, oral, and intravenous. The oral segment is expected to hold a larger share of the market share owing to the rising demand for the drugs. The distribution channel segment of the market consists of hospital pharmacies, retail pharmacies, and online pharmacies. The retail pharmacies segment is expected to hold the largest share of the market as there are a repetitive purchase of medicines from these locations. Key Players Some of the key players in the Global Pseudomonas Aeruginosa Treatment Market are Pfizer, Inc. (UK), Gilead Sciences Inc (US), Lupin Pharmaceuticals, Inc. (US), Teva Pharmaceutical Industries Ltd. (Israel), Novartis AG (Switzerland), PARI Medical Holding GmbHb (Germany), AstraZeneca (UK), Humanigen Inc (US), Merck & Co., Inc. (US), AmpliPhi Biosciences Corp (US), Bristol-Myers Squibb Co.(US), Aradigm Corp (US), Allergan Plc (Ireland), Janssen Pharmaceuticals, Inc.(Belgium), and Bayer AG (Germany). Regional Analysis The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. Americas has been segmented into North America and Latin America, with the North American market being divided into the US and Canada. The Americas is projected to hold the largest market share owing to the increasing number of surgical sites infection and increasing demand for antibiotics to treat the same drives the market growth during the forecasted period. The European Pseudomonas Aeruginosa treatment market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The Pseudomonas Aeruginosa treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the rising geriatric population and the presence of a large patient pool, the market in Asia-Pacific is expected to be the fastest-growing. The Pseudomonas Aeruginosa Treatment market in the Middle East & Africa has been divided into the Middle East and Africa. get full report @ https://www.marketresearchfuture.com/reports/pseudomonas-aeruginosa-treatment-market-8438 Related News Sex Cord Gonadal Stromal Tumor Market Bariatric Surgery Devices Market About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. https://www.marketresearchfuture.com/ According to MRFR analysis, Biopharmaceuticals Market is expected to register a CAGR of 8.99% during the forecast period of 2019 to 2025 and was valued at USD 238,192.7 million in 2018.
Biopharmaceuticals are also known as biological, medical products, or biologics, are pharmaceutical drugs manufactured, extracted, or synthesized using biological sources, such as bacteria, yeast, and mammalian cells. The global biopharmaceuticals market is growing owing to various factors such as increasing investment by major companies on research & development of biopharmaceuticals and increasing acceptance for biopharmaceuticals due to their ability to treat the previously untreatable diseases. Furthermore, the number of geriatric populations is, tremendously, the incidence rate of chronic diseases is also high, and technological advancements are growing which are also expected to fuel the market growth. However, the entry of low-cost biosimilars, risk of side effects that can occur due to high usage of biopharmaceuticals, and stringent government regulations are expected to pose as restraints to the growth of the global biopharmaceuticals market. Key Players Some of the key players in the Global Biopharmaceuticals Market are Pfizer Inc. (US), Amgen Inc. (US), Eli Lilly and Company (US), F. Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson (US), Gilead Sciences, Inc. (US), AstraZeneca (UK), Abbvie Inc. (US), Sanofi (France), Bristol-Myers Squibb Company (US), Sandoz International GmbH (Germany), Novo Nordisk A/S (Denmark), GlaxoSmithKline PLC (UK), Merck KGaA (Germany), and Biocon (India). Segmentation The global biopharmaceuticals market has been segmented based on product type and application. The global biopharmaceuticals market has been segmented, on the basis of product type, into monoclonal antibodies, recombinant growth factors, purified proteins, recombinant proteins, recombinant hormones, vaccines, synthetic immunomodulators, and others. The recombinant growth factors has been further bifurcated into erythropoietin and granulocyte colony-stimulating factor. The purified proteins segment has been further classified as leukemia inhibitory factor (LIF), P53 protein, P38 protein, and others. The recombinant proteins segment has been further divided into serum albumin, amyloid protein, defensin, transferrin, and others. Vaccines have also been segregated into recombinant vaccines, conventional vaccines, and others. The recombinant vaccines have been further sub-segmented into cancer vaccines, malaria vaccines, Ebola vaccines, hepatitis B vaccines, tetanus vaccines, diphtheria vaccines, cholera vaccines, and others. Conventional vaccines have been categorized as polio vaccines, pox vaccines, and others. Synthetic immunomodulators segment has been further divided into cytokines, interferons, interleukins, tumor necrosis factor (TNF), and others. Monoclonal antibodies segment is anticipated to hold the largest market share in the global biopharmaceutical market due to the increasing number of research activities that are supported by the usage of monoclonal antibodies. Vaccines are expected to grow at the fastest CAGR owing to the rising awareness of chronic diseases. Regional Analysis The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the increasing prevalence of chronic diseases. The biopharmaceuticals market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European biopharmaceuticals market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The biopharmaceuticals market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing patient pool suffering from various chronic diseases and a supportive regulatory framework, the market in Asia-Pacific is expected to be the fastest-growing. The biopharmaceuticals market in the Middle East & Africa has been divided into the Middle East and Africa. Get full report @https://www.marketresearchfuture.com/reports/biopharmaceuticals-market-8439 Related News Sex Cord Gonadal Stromal Tumor Market Bariatric Surgery Devices Market About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. https://www.marketresearchfuture.com/ Industry Report “Lymphedema Treatment Market Research Report — Global Forecast till 2025” provides a clear picture of the Current Market Scenario which includes past and estimated future size with respect to value and volume, technological advancement, macro economical and governing factors in the Lymphedema Treatment Market.
Lymphedema Treatment Market is estimated to grow with a CAGR of 4.0%. Market Synopsis The increasing prevalence of cancer is expected to drive the Global Lymphedema Treatment Market. The strong clinical pipeline is likely to boost the market growth. Market players like HERANTIS PHARMA PLC, are developing curative treatment of secondary lymphedema — Lymfactin. Lymfactin is the world’s first and only clinical-stage gene therapy against lymphedema. The market potential of the drug is estimated to be around USD 650 Million. Market Influencer Increased research & development in the market is estimated to influence the commercialization in the market. The market is projected to witness a shift from symptomatic treatments to targeted treatment during the forecast period of 2018 to 2025. Key Players
By Type
Market Influencer Increased research & development in the market is estimated to influence the commercialization in the market. The market is projected to witness a shift from symptomatic treatments to targeted treatment during the forecast period of 2018 to 2025. Related News Pseudomonas Aeruginosa Treatment Market Behavioral Health Services Market The increased integration of technology in healthcare is promoting the use of Biosensorss favorably. Reports that appraise the healthcare industry have been presented by Market Research Future, which creates reports on industry verticals that assess the Biosensor market development and projections. The market is anticipated to perceive a CAGR of 9.6 % approximately from 2014 to 2020.
Table of Content Chapter 3. Market Outlook 3.1 Introduction 3.2 Trends in the Market 3.2.1 Rising product innovation 3.2.2 Technological advancement of Biosensorss leading to miniaturizations of sensors 3.3 Opportunities in the Market 3.3.1 Opportunity from increasing demand of personalized medicine 3.4 Factors Driving the Market and its Impact on Market Forecast 3.4.1 Rising aging population 3.4.2 Increasing diabetic population 3.4.3 Rising prevalence of chronic and lifestyle induced disease 3.4.4 Increasing demand for POCT 3.4.5 Increasing application of Biosensorss in various industries 3.4.6 Impact analysis of drivers on market forecast 3.5 Factors Hindering the Market and its Impact on Market Forecast 3.5.1 Strict regulatory requirements 3.5.2 Reimbursement policies issues in healthcare systems 3.5.3 Impact analysis of restraints on market forecast Continued…. Biosensors market Segmentation: By technology, the market divides into thermal Biosensorss, electrochemical Biosensorss, piezoelectric Biosensorss, optical Biosensorss, and others. The piezoelectric Biosensorss hold the largest share in this market segment. By application, the market includes industrial process, agricultural testing, medical testing, environmental market, into food toxicity, and others. By end-user, the market comprises research laboratories, security and biodefense, food industry, point of care, home diagnostics, and others. The security and biodefence segment is the biggest market share holder because of the increasing biological threats and the proliferating need to protect them. Collect detailed information of Biosensors Market segmented by technology by end user, by application (medical testing, food toxicity, industrial process, environmental market, agricultural testing, others) - Forecast to 2020 @ https://www.marketresearchfuture.com/reports/Biosensors-market-1228 Competitive Landscape The global Biosensors market holds a number of key players including Nova Biomedical Corporation, F. Hoffmann-La Roche Ltd., TiaDoc Technology Corporation, LifeSensors Inc., Medtronic, Inc., Siemens Healthcare, Abbott Laboratories Inc., I-SENCE Inc., Johnson & Johnson, and Bayer Healthcare. Browse other healthcare Related Report Non-Invasive Prenatal Testing Market |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
October 2021
Categories |